HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark S Freedman Selected Research

Alanine Transaminase (SGPT)

1/2016Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions.
11/2014Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial.
10/2014Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
3/2014Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark S Freedman Research Topics

Disease

124Multiple Sclerosis
05/2024 - 06/2002
25Relapsing-Remitting Multiple Sclerosis
12/2023 - 01/2008
13Disease Progression
02/2024 - 02/2003
9Inflammation (Inflammations)
03/2024 - 04/2010
7Atrophy
01/2023 - 03/2017
5Fatigue
01/2021 - 01/2014
5Chronic Progressive Multiple Sclerosis
10/2020 - 10/2009
4Infections
10/2020 - 10/2009
4Demyelinating Diseases (Demyelinating Disease)
09/2012 - 02/2008
3Neuromyelitis Optica (Devic's Disease)
01/2024 - 09/2012
3Optic Neuritis (Retrobulbar Neuritis)
10/2018 - 06/2006
2Stroke (Strokes)
01/2024 - 07/2011
2Neoplasms (Cancer)
01/2023 - 06/2003
2COVID-19
11/2021 - 10/2020
2Lymphopenia (Lymphocytopenia)
01/2020 - 03/2016
2Dizziness (Lightheadedness)
01/2017 - 11/2014
2Headache (Headaches)
01/2016 - 03/2014
2Diarrhea
01/2016 - 10/2011
2Nausea
01/2016 - 10/2011
2Human Influenza (Influenza)
11/2014 - 08/2013
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2013 - 07/2011
1Parkinson Disease (Parkinson's Disease)
01/2024
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2024
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2024
1Obesity
01/2024
1Pathologic Processes
01/2024
1Nervous System Diseases (Neurological Disorders)
01/2024
1Alzheimer Disease (Alzheimer's Disease)
01/2024
1Frontotemporal Dementia With Motor Neuron Disease
01/2024
1Infertility (Sterility)
01/2023
1Body Weight (Weight, Body)
01/2023
1Myasthenia Gravis
01/2023
1Herpes Zoster
07/2021
1Severe Acute Respiratory Syndrome
10/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Weight Gain
10/2018
1Neuroinflammatory Diseases
04/2017
1Exanthema (Rash)
01/2017
1Atrioventricular Block
03/2016
1Bradycardia
03/2016
1Basal Cell Carcinoma (Rodent Ulcer)
03/2016
1Bronchiolitis Obliterans Syndrome
01/2016
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016

Drug/Important Bio-Agent (IBA)

25teriflunomideIBA
01/2023 - 10/2011
11Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2014
9Fingolimod Hydrochloride (FTY720)FDA Link
02/2024 - 09/2014
9Interferon beta-1aFDA Link
01/2024 - 04/2004
9Interferon beta-1b (Betaseron)FDA Link
01/2020 - 08/2007
8GadoliniumIBA
11/2016 - 02/2008
7CladribineFDA LinkGeneric
10/2023 - 03/2014
6ponesimodIBA
02/2024 - 11/2014
6Alemtuzumab (Campath)FDA Link
01/2023 - 07/2013
6InterferonsIBA
01/2023 - 03/2014
5Sphingosine-1-Phosphate ReceptorsIBA
02/2024 - 11/2014
5TabletsIBA
10/2023 - 10/2017
5AntibodiesIBA
01/2019 - 01/2007
5Immunologic Factors (Immunomodulators)IBA
01/2018 - 08/2013
4diroximel fumarateIBA
12/2023 - 01/2020
4Therapeutic UsesIBA
01/2023 - 07/2011
4Retinaldehyde (Retinal)IBA
10/2018 - 06/2006
4Alanine Transaminase (SGPT)IBA
01/2016 - 03/2014
3ocrelizumabIBA
04/2024 - 01/2022
3Natalizumab (Tysabri)FDA Link
03/2024 - 01/2018
3siponimodIBA
02/2024 - 08/2013
3sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2024 - 01/2016
3Immunoglobulin G (IgG)IBA
01/2024 - 01/2007
3Vitamin DFDA LinkGeneric
01/2024 - 03/2014
3Complement System Proteins (Complement)IBA
01/2023 - 10/2010
3Interferon-betaIBA
01/2012 - 08/2007
2Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2017
2SteroidsIBA
01/2023 - 03/2014
2FumaratesIBA
11/2020 - 01/2020
2Dimethyl FumarateIBA
01/2020 - 11/2016
2Oligoclonal BandsIBA
01/2018 - 04/2009
2Monoclonal AntibodiesIBA
10/2009 - 08/2008
2Rituximab (Mabthera)FDA Link
10/2009 - 08/2008
1ozanimodIBA
02/2024
1Thioctic Acid (Lipoic Acid)IBA
01/2023
1GelsIBA
11/2021
1Biotin (Vitamin H)FDA Link
12/2020
1opicinumabIBA
10/2018
1Busulfan (Busulfex)FDA Link
01/2018
1SodiumIBA
07/2017
1SaltsIBA
07/2017
1Abatacept (Orencia)FDA Link
04/2017
1Minocycline (Cyclops)FDA LinkGeneric
01/2017

Therapy/Procedure

45Therapeutics
05/2024 - 05/2004
13Hematopoietic Stem Cell Transplantation
05/2022 - 08/2010
4Drug Therapy (Chemotherapy)
01/2020 - 03/2013
3Stem Cell Transplantation
03/2024 - 02/2008
3Treatment Delay
01/2022 - 11/2009
3Transplantation
01/2019 - 04/2010
2Mesenchymal Stem Cell Transplantation
01/2022 - 04/2010
1Hematopoietic Stem Cell Mobilization
05/2022
1Transcranial Magnetic Stimulation
01/2022
1Critical Care (Surgical Intensive Care)
11/2021
1Immunotherapy
10/2020
1Precision Medicine
01/2020
1Cell Transplantation
01/2019
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2017